These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32711010)

  • 21. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
    Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
    Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive Value of In Vivo MR Spectroscopy With Semilocalization by Adiabatic Selective Refocusing in Differentiating Clear Cell Renal Cell Carcinoma From Other Subtypes.
    Ali HA; Couch MJ; Menezes R; Evans AJ; Finelli A; Jewett MA; Jhaveri KS
    AJR Am J Roentgenol; 2020 Apr; 214(4):817-824. PubMed ID: 32045306
    [No Abstract]   [Full Text] [Related]  

  • 23. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
    Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
    Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
    Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical diagnosis of renal neoplasms.
    Truong LD; Shen SS
    Arch Pathol Lab Med; 2011 Jan; 135(1):92-109. PubMed ID: 21204715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
    Halefoglu AM; Ozagari AA
    Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Performance and Interreader Agreement of a Standardized MR Imaging Approach in the Prediction of Small Renal Mass Histology.
    Kay FU; Canvasser NE; Xi Y; Pinho DF; Costa DN; Diaz de Leon A; Khatri G; Leyendecker JR; Yokoo T; Lay AH; Kavoussi N; Koseoglu E; Cadeddu JA; Pedrosa I
    Radiology; 2018 May; 287(2):543-553. PubMed ID: 29390196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circularity Index on Contrast-Enhanced Computed Tomography Helps Distinguish Fat-Poor Angiomyolipoma from Renal Cell Carcinoma: Retrospective Analyses of Histologically Proven 257 Small Renal Tumors Less Than 4 cm.
    Kang HS; Park JJ
    Korean J Radiol; 2021 May; 22(5):735-741. PubMed ID: 33660463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated differentiation of benign renal oncocytoma and chromophobe renal cell carcinoma on computed tomography using deep learning.
    Baghdadi A; Aldhaam NA; Elsayed AS; Hussein AA; Cavuoto LA; Kauffman E; Guru KA
    BJU Int; 2020 Apr; 125(4):553-560. PubMed ID: 31901213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computer approach to recognition of Fuhrman grade of cells in clear-cell renal cell carcinoma.
    Kruk M; Osowski S; Markiewicz T; Slodkowska J; Koktysz R; Kozlowski W; Swiderski B
    Anal Quant Cytopathol Histpathol; 2014 Jun; 36(3):147-60. PubMed ID: 25141491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical use of a machine learning histopathological image signature in diagnosis and survival prediction of clear cell renal cell carcinoma.
    Chen S; Zhang N; Jiang L; Gao F; Shao J; Wang T; Zhang E; Yu H; Wang X; Zheng J
    Int J Cancer; 2021 Feb; 148(3):780-790. PubMed ID: 32895914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study.
    Mileto A; Marin D; Alfaro-Cordoba M; Ramirez-Giraldo JC; Eusemann CD; Scribano E; Blandino A; Mazziotti S; Ascenti G
    Radiology; 2014 Dec; 273(3):813-20. PubMed ID: 25162309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-Tesla dynamic contrast-enhanced MRI: a critical assessment of its use for differentiation of renal lesion subtypes.
    Sevcenco S; Ponhold L; Javor D; Kuehhas FE; Mauermann J; Miernik A; Schoenthaler M; Baltzer PA
    World J Urol; 2014 Feb; 32(1):215-20. PubMed ID: 24105251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical shift magnetic resonance imaging for distinguishing minimal-fat renal angiomyolipoma from renal cell carcinoma: a meta-analysis.
    Chen LS; Zhu ZQ; Wang ZT; Li J; Liang LF; Jin JY; Wang ZQ
    Eur Radiol; 2018 May; 28(5):1854-1861. PubMed ID: 29178029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Semantic interpretation of robust imaging features for Fuhrman grading of renal carcinoma.
    Champion A; Lu G; Walker M; Kothari S; Osunkoya AO; Wang MD
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():6446-9. PubMed ID: 25571472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep learning with a convolutional neural network model to differentiate renal parenchymal tumors: a preliminary study.
    Zheng Y; Wang S; Chen Y; Du HQ
    Abdom Radiol (NY); 2021 Jul; 46(7):3260-3268. PubMed ID: 33656574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of an eight-gene expression signature for predicting high Fuhrman grade renal cell carcinoma.
    Wan F; Zhu Y; Han C; Xu Q; Wu J; Dai B; Zhang H; Shi G; Gu W; Ye D
    Int J Cancer; 2017 Mar; 140(5):1199-1208. PubMed ID: 27874173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Accuracy of Unenhanced CT Analysis to Differentiate Low-Grade From High-Grade Chromophobe Renal Cell Carcinoma.
    Schieda N; Lim RS; Krishna S; McInnes MDF; Flood TA; Thornhill RE
    AJR Am J Roentgenol; 2018 May; 210(5):1079-1087. PubMed ID: 29547054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.